Skip to main content
. 2011 Aug 8;108(36):14725–14732. doi: 10.1073/pnas.1110900108

Fig. 3.

Fig. 3.

Certain inhibitory NK receptors are underrepresented on the CD57+NKG2Chi NK cell subset from CMV+ donors. (A) CD56dimCD16+ NK cells from CMV (Left) and CMV+ (Right) donors were gated and analyzed for expression of CD57 and NKG2C. CD57+NKG2C (a), CD57+NKG2Cdim (b), and CD57+NKG2Chi (c) NK cells were assessed for CD56 and NKG2A expression. (B) The percentage of NKG2A+ cells was determined on CD57+NKG2C and CD57+NKG2Chi NK cells from CMV+ donors (n = 16). (C) The percentage of KIR3DL1+ cells was determined on CD57+NKG2C and CD57+NKG2Chi NK cells from CMV+ donors. Graphs from HLA-Bw4+ (Upper; n = 9) and HLA-Bw4 donors (Lower; n = 6) are shown. (D) The percentage of KIR2DL1+ cells was determined on CD57+NKG2C and CD57+NKG2Chi NK cells for CMV+ donors who have the KIR2DL1 ligand (Left; n = 5) or do not (Right; n = 7).